GKWIM
GILD icon

Gerber Kawasaki Wealth & Investment Management’s Gilead Sciences GILD Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20
Closed -$16K – 133
2020
Q2 		$16K Buy
+20
New +$1.53K ﹤0.01% 135

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's GILD Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 6,119 shares — an estimated $427K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in GILD in Q4 2015 and held it in 15 quarters. The position peaked at $12.1M in Q4 2015. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 6,119 Gilead Sciences shares in Q4 2021, an estimated $427K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Gilead Sciences in Q4 2015 and held it in 15 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Gilead Sciences position peaked at $12.1M in Q4 2015.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.